Cardiology

Snake venom might provide a safer antiplatelet drug

Researchers have designed a safer antiplatelet drug based on a snake venom, according to new research in Arteriosclerosis, Thrombosis and Vascular Biology, an American Heart Association journal.

Immunology

Platelets suppress T cell immunity against cancer

Blood platelets help disguise cancer from the immune system by suppressing T cells, report scientists at the Medical University of South Carolina (MUSC) in the May 5, 2017 issue of Science Immunology. In extensive preclinical ...

Cardiology

Major bleeding risk from drugs similar in elderly

(HealthDay)—The risk of major bleeding is similar for older patients with atrial fibrillation taking either antiplatelet or anticoagulant drugs, according to a review published online April 10 in the Journal of Thrombosis ...

Cardiology

PPI cuts risk of warfarin-related upper GI bleeding

(HealthDay)—For patients beginning warfarin therapy, proton pump inhibitor (PPI) co-therapy is associated with reduced risk of upper gastrointestinal bleeding, according to a study published in the December issue of Gastroenterology.

Cardiology

Ballooning platelets and the future of anti-thrombotic drugs

Membrane ballooning in platelets during the blood-clotting process is driven by a coordinated system of salt and water entry which may be modified pharmacologically, a new study from the University of Bristol has found. The ...

Cardiology

Review: SSRI use ups risk of upper GI bleeding

(HealthDay)—Selective serotonin reuptake inhibitor (SSRI) use is associated with increased risk of upper gastrointestinal bleeding (UGIB), according to a meta-analysis published in the January issue of Clinical Gastroenterology ...

Cardiology

Heart attack treatments ineffective for some

Victoria University of Wellington research has identified reasons why a significant portion of heart attack patients do not respond to commonly used treatments.

page 2 from 4